CH
抗体药类似物
Research Grade Remtolumab
All
  • CatalogTD-HS856096
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBispecific, A-1230717, ABT-122, CAS: 1791410-27-9
  • Specification
    1mg
  • Prices
    ¥询价
Customized service consulting

Research Grade Remtolumab


Catalog No. TD-HS856096
Species reactivity Human
Applications Research Grade Biosimilar
Host species Human
Isotype [VH-VH'-H-Gamma1-VL-VL'-C-kappa]-dimer
Expression system Mammalian Cells
Species Human
Clonality Monoclonal
Target CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A, TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a, TNF-alpha, Tumor necrosis factor, TNFSF2, TNFA, Cachectin, ICD1
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession Q16552 & P01375
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternate Names Bispecific, A-1230717, ABT-122, CAS: 1791410-27-9
Background Remtolumab (ABT-122) is a dual-variable domain immunoglobulin that neutralises both tumor necrosis factor α (TNFα) and IL-17A. Remtolumab shows dual inhibition of TNFα and IL-17A. Remtolumab can be used for rheumatoid arthritis (RA) research.
Note For research use only. Not suitable for clinical or therapeutic use.